Clinical Trials in Immune Tolerance supports scientists conducting clinical trials, tolerance assays, and mechanistic studies to induce and understand immune tolerance across four disease areas.
Funder: Immune Tolerance Network
Due Dates: Rolling (Concept Proposals) | January 15, 2027 (Liver Transplant RFP: Letter of Interest review begins)
Funding Amounts: Not specified
Summary: Supports clinical trials, tolerance assays, and mechanistic studies to induce and understand immune tolerance across four disease areas.
Key Information: Scientists from academia, industry, and government may apply; non-human and preclinical studies are not accepted.
The Immune Tolerance Network (ITN) accepts proposals for novel clinical trials built around testable hypotheses for inducing immune tolerance. Its scope spans allergy and asthma, autoimmune disease, transplantation, and type 1 diabetes. ITN is an international clinical research consortium supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, with a collaborative approach to developing and evaluating tolerance therapies.
Alongside trials, ITN supports novel tolerance assays and mechanistic studies that establish surrogate biomarkers or investigate mechanisms of clinical tolerance. Proposals may also use ITN tolerance-assay resources within existing or planned trials funded elsewhere. Targeted requests seek mechanistically focused environmental allergen immunotherapy trials and tolerance trials in adult liver transplantation.